Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and IMRT in Low-Risk Nasopharyngeal Carcinoma
NCT02237924Phase 2Completed
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Sep 2014
- Primary completion
- Sep 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by The First Affiliated Hospital of Guangxi Medical University. Started Sep 2014; status: completed.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02237924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237924.